Ameritas Investment Partners, Inc. - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$7,000
-22.2%
14,9140.0%0.00%
Q4 2021$9,000
-64.0%
14,9140.0%0.00%
-100.0%
Q3 2021$25,0000.0%14,9140.0%0.00%0.0%
Q2 2021$25,000
+525.0%
14,914
+108.4%
0.00%
Q1 2019$4,000
+33.3%
7,1580.0%0.00%
Q4 2018$3,000
-25.0%
7,1580.0%0.00%
Q3 2018$4,000
-75.0%
7,1580.0%0.00%
-100.0%
Q2 2018$16,000
+433.3%
7,158
+109.1%
0.00%
Q1 2017$3,0003,4230.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 291,500$137,0000.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$441,0000.14%
CVA Family Office, LLC 1,137,920$535,0000.13%
Cypress Capital Management LLC (WY) 179,525$84,0000.10%
Willis Investment Counsel 2,075,840$976,0000.05%
NTB Financial Corp 146,100$69,0000.05%
SRS Capital Advisors, Inc. 629,172$296,0000.04%
Helen Stephens Group, LLC 117,222$55,0000.04%
COURIER CAPITAL LLC 464,356$218,0000.02%
Western Wealth Management, LLC 946,800$444,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders